- This event has passed.
CTL@WCM Special Panel on Healthcare Data Commercialization
March 30 @ 12:00 pm - 1:00 pm
The Center for Technology Licensing (CTL) at Weill Cornell is pleased to present the next in the CTL@WCM Special Panel Series.
“Healthcare Data Commercialization: What are we worried about?”
Healthcare data and ‘Big Data’ technology brings the promise of advances in research, patient care and outcomes, and other economic benefits. Companies will continue to play a central role in delivering data-driven innovations but will require access, use, and control of massive amounts of patient data in the process. What could go wrong?
Moderated by Lisa Placanica, Senior Managing Director, CTL @ WCM
The invited panel of experts in the field will explore topics of privacy, commerce, and safety in healthcare data commercialization:
Curtis L. Cole, M.D. Chief Global Information Officer at Cornell University responsible for developing institutional strategy and policy for digital technology capabilities for all university campuses, including Ithaca, Cornell Tech in New York City, Weill Cornell Medicine in New York City and Qatar, Cornell AgriTech in Geneva, New York, and off-campus sites around the world.
Deven McGraw, J.D., M.P.H. Lead for Data Stewardship and Data Sharing at Invitae; Co-Founder and Chief Regulatory Officer for Ciitizen, a platform for patients to gather their health information (acquired by Invitae). Former Deputy Director for Health Information Privacy at the Office for Civil Rights of the U.S. Dept. of Health and Human Services. Enforcer of HIPAA rights.
Jason Novak, J.D. Partner at Norton Rose Fulbright, focusing on IP protection strategies and data rights transactions and strategies supporting the firm’s Digital Health and Precision Medicine initiative. He advises large and small entities on the various legal issues that can arise with emerging technologies in the healthcare and life sciences industries.
Roger Kuan, J.D. Partner at Norton Rose Fulbright and US Head of the Digital Health and Precision Medicine IP Practice. He counsels companies uniquely positioned in the convergence of the life/medical sciences and technology industries on how to successfully navigate the complexities of the intellectual property (IP), data rights, and regulatory challenges they encounter.